mirtazapine has been researched along with Idiopathic Parkinson Disease in 7 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mirtazapine-treated neuron-conditioned medium (Mir-NCM) induced astrocyte proliferation and upregulated MT expression via 5-HT1A receptors on astrocytes." | 1.56 | Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection. ( Asanuma, M; Kagawa, D; Kikuoka, R; Kitamura, Y; Kubota, N; Maeda, M; Miyazaki, I; Moriyama, M; Murakami, S; Sato, A; Sendo, T, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuoka, R | 1 |
| Miyazaki, I | 1 |
| Kubota, N | 1 |
| Maeda, M | 1 |
| Kagawa, D | 1 |
| Moriyama, M | 1 |
| Sato, A | 1 |
| Murakami, S | 1 |
| Kitamura, Y | 1 |
| Sendo, T | 1 |
| Asanuma, M | 1 |
| Tagai, K | 2 |
| Nagata, T | 2 |
| Shinagawa, S | 2 |
| Tsuno, N | 1 |
| Ozone, M | 1 |
| Nakayama, K | 2 |
| Hagikura, M | 1 |
| Iwamoto, K | 1 |
| Aleksic, B | 1 |
| Ozaki, N | 1 |
| Gordon, PH | 1 |
| Pullman, SL | 1 |
| Louis, ED | 1 |
| Frucht, SJ | 1 |
| Fahn, S | 1 |
| Normann, C | 1 |
| Hesslinger, B | 1 |
| Frauenknecht, S | 1 |
| Berger, M | 1 |
| Walden, J | 1 |
| Pact, V | 1 |
| Giduz, T | 1 |
7 other studies available for mirtazapine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection.
Topics: Animals; Antioxidants; Astrocytes; Cells, Cultured; Dopamine; Dopaminergic Neurons; Female; Male; Me | 2020 |
Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
Topics: Aged, 80 and over; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Female; Halluc | 2013 |
What is a rational antidepressant treatment for major depression in patients with Parkinson's disease?
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Humans; Mianserin; Middle Aged | 2012 |
A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease.
Topics: Antidepressive Agents, Tricyclic; Basal Ganglia Diseases; Depressive Disorder; Female; Hallucination | 2013 |
Mirtazapine in Parkinsonian tremor.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mir | 2002 |
Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
Topics: Adult; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Depressive Disorder; Drug Interaction | 1997 |
Mirtazapine treats resting tremor, essential tremor, and levodopa-induced dyskinesias.
Topics: Adrenergic alpha-Antagonists; Aged; Dyskinesia, Drug-Induced; Dyskinesias; Female; Humans; Levodopa; | 1999 |